
Michael J. Sheppeard
Partner
212-784-6939 msheppeard@sh-law.comFirm Insights
Author: Michael J. Sheppeard
Date: September 29, 2020

Partner
212-784-6939 msheppeard@sh-law.comAlthough COVID-19 remains a top compliance concern for New York and New Jersey employers, it’s important to remember that regulators continue to address a wide range of other issues. On August 5, 2020, the Equal Employment Opportunity Commission (EEOC) released new guidance regarding opioid addiction and employment.

Opioid misuse and associated overdoses have become a public health crisis over the past several years. By definition, “opioids” include prescription drugs such as codeine, morphine, oxycodone, hydrocodone, and meperidine, as well as illegal drugs like heroin.
In 2016, opioid overdoses accounted for more than 42,000 deaths, more than any previous year on record. Of the overdose deaths, approximately 40% involved a prescription opioid. Data collected in 2018 data shows that 128 people in the United States die after overdosing on opioids every day.
The opioid crisis does not just impact drug users and their families. According to the Centers for Disease Control and Prevention estimates that the total “economic burden” of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.
Opioids are also a concern for employers. Substance use disorder impacts workplace safety, health care costs, productivity, absenteeism, and job performance.
The EEOC’s recent guidance, Use of Codeine, Oxycodone, and Other Opioids: Information for Employees, addresses how employers must address opioid use by employees under the ADA. It makes clear that current illegal drug use is not a covered disability. Accordingly, if a worker is using heroin or opioid medication without a valid prescription, the ADA does not prohibit employers from firing employees, denying employment to job applicants, or taking other negative employment actions based on the current illegal use of drugs.
Conversely, workers who are lawfully using opioid medication, are in treatment for opioid addiction and are receiving Medication-Assisted Treatment (MAT), or have been in recovery for their addiction, are protected from discrimination under the ADA. Accordingly, if an employee’s opioid use is legal, employers can’t automatically disqualify the employee because of opioid use without considering if there is a way for the employee to perform the job safely and effectively. In such cases, employers may be required to provide a reasonable accommodation.
Below are several other key takeaways from the EEOC guidance:
The EEOC also published additional guidance aimed at health professionals. The document, entitled “How Health Care Providers Can Help Current and Former Patients Who Have Used Opioids Stay Employed,” addresses patients’ legal rights in the workplace. As the EEOC notes, medical providers are often key participants in the interactive process between employers and workers as employers seek to understand the employee’s condition and potential need for reasonable accommodation. The fact sheet provides an overview of ADA coverage and offers guidance to health care workers seeking to provide documentation of covered disabilities on behalf of their patients.
While opioid-related deaths declined in 2019, health experts expect that the ongoing COVID-19 pandemic will fuel the crisis. To maintain a healthy workplace, employers should encourage workers to use their health insurance as well as any available Employee Assistance Program (EAP) to address their mental or chemical health needs. Employers may also want to consider policies and procedures that promote overall wellness and self-care, support long-term recovery, and seek to reduce stigma surrounding drug use for those seeking assistance. With regard to regulatory compliance, it is important that employers understand their obligations under laws like ADA. As the EEOC guidance highlights, employers have certain obligations to accommodate an employee’s opioid use and treatment for opioid addiction under the law.
If you have any questions or if you would like to discuss the matter further, please contact me, Michael Sheppeard, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

What should you expect when meeting a litigation attorney about a business dispute? You should expect to describe the dispute in your own words, hand over the most important documents, flag any deadlines or immediate threats, and leave with a clearer picture of the problem, what information is still needed, and the likely next steps. […]
Author: Michael Mietlicki

Arbitration resolves disputes privately before an arbitrator whose decision is usually final, while litigation resolves them in court with full rights of appeal. Whether a business ends up in arbitration or litigation is often decided when it signs the contract, long before any dispute arises. Key Takeaways When facing a contract dispute, carefully consider your […]
Author: Graham Staton

Can you own part of a business in New Jersey without a written agreement? Yes, it is possible. Under New Jersey’s Uniform Partnership Act, a partnership can arise when two or more people carry on a business as co-owners for profit, whether or not they ever intended to form one. Ownership doesn’t necessarily depend on […]
Author: Michael Mietlicki

For New Jersey businesses, crisis preparedness should be viewed as a legal and operational function, not simply an emergency-management exercise. A well-designed crisis response plan can help preserve evidence, protect confidential communications, meet reporting obligations, limit unnecessary exposure, and prevent an already difficult situation from becoming a larger legal problem. Key Takeaways A serious crisis […]
Author: Sean M. Pena

Monmouth County is entering a significant new phase of development. For those looking to acquire property or undertake a new project, understanding the market opportunity is only the beginning. The more important question is whether a particular property can actually be developed as contemplated and what approvals, agreements, and other conditions will be required to […]
Author: Donald M. Pepe

Whether a client’s prompts to a generative AI tool and the documents it produces are protected from disclosure depends on the case type, who claims protection, and whether counsel was involved. In United States v. Heppner, a New York federal judge ruled that a criminal defendant’s communications with an AI platform were protected by neither […]
Author: Chris Seelinger
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!